H1B Report
H-1B sponsorNJFEIN 02-0567016Updated Jun 2026

Novartis Institutes for BioMedical Research, Inc.

US H-1B Labor Condition Application activity for Novartis Institutes for BioMedical Research, Inc.. Filed 943 disclosures between FY2010 and FY2026 from worksites with a NJ headquarters indicator.

Total filings
36
Outside top-N · FY2026
Certified
100.0%
unconditional · FY2026
Withdrawn
0.0%
withdrawn rate · FY2026
Denied
0.0%
rejection rate · FY2026

H-1B outcome breakdown

Share of Novartis Institutes for BioMedical Research, Inc.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.

Outcome breakdown: Certified 100.0%
Outcome breakdown
OutcomeShare
Certified100.0%
Certified100.0%

Top occupations sponsored

SOC codes filed most by Novartis Institutes for BioMedical Research, Inc. across all fiscal years. Click any row to open the national salary guide.

#SOCTitleFilings
119-1042Medical Scientists, Except Epidemiologists177
217-2076Electronics Engineers, Except Computer, R&D144
319-1022Microbiologists103
419-1029Biological Scientists, All Other70
533-3021Detectives and Criminal Investigators67
625-1072Nursing Instructors and Teachers, Postsecondary60
719-4021Biological Technicians39
815-2041Statisticians35
915-2051Data Scientists34
1019-1021Biochemists and Biophysicists31

H-1B filings by fiscal year

Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.

YearFilings
FY201064
FY201154
FY201264
FY201358
FY201480
FY201568
FY201676
FY201781
FY201862
FY201970
FY20204
FY20219
FY20226
FY202313
FY2024106
FY202592
FY202636
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201064
FY201154
FY201264
FY201358
FY201480
FY201568
FY201676
FY201781
FY201862
FY201970
FY20204
FY20219
FY20226
FY202313
FY2024106
FY202592
FY202636
Compare Novartis Institutes for BioMedical Research, Inc. with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Popular comparisons
Explore by rank
Pre-built leaderboards for the most-asked questions.